Clinical Features, Response to Treatment, and Outcomes of IgG4-Related Sclerosing Cholangitis

In a retrospective cohort study of 527 patients with IgG4-SC in Japan, we found the disease to be benign. Most patients (90%) respond to treatment with prednisolone and few develop decompensated cirrhosis or cholangiocarcinoma.